Uptake of HIV screening in genitourinary medicine after change to "opt-out" consent.
about
The impact of provider-initiated (opt-out) HIV testing and counseling of patients with sexually transmitted infection in Cape Town, South Africa: a controlled trial.Recruiting patients to medical research: double blind randomised trial of "opt-in" versus "opt-out" strategiesEstimation of HIV-testing rates to maximize early diagnosis-derived benefits at the individual and population levelOlder HIV-infected individuals present late and have a higher mortality: Brighton, UK cohort study.Integrating routine HIV testing into a public health STD clinic.Projected survival gains from revising state laws requiring written opt-in consent for HIV testing.General internists' beliefs, behaviors, and perceived barriers to routine HIV screening in primary careA Comparison of Patient Satisfaction with Emergency Department Opt-In and Opt-Out Rapid HIV Screening.CD4 Counts at Entry to HIV Care in Mexico for Patients under the "Universal Antiretroviral Treatment Program for the Uninsured Population," 2007-2014HIV pre-test information, discussion or counselling? A review of guidance relevant to the WHO European Region.A comparison of effectiveness between oral rapid testing and routine serum-based testing for HIV in an outpatient dental clinic in Yuxi Prefecture, China: a case-control study.Reducing the length of time between HIV infection and diagnosis.HIV opt-out increases HIV testing in low-risk patients.Opt-out testing for HIV: perspectives from a high prevalence community in south-east England, UK.Low HIV-testing rates and awareness of HIV infection among high-risk heterosexual STI clinic attendees in The Netherlands.Effects of written informed consent requirements on HIV testing rates: evidence from a natural experiment
P2860
Q33673978-CE4D73E0-253D-40F2-89E3-0A42DED08379Q34089775-E6E14964-8FA7-449C-877D-01F3DA9AB925Q34544751-7C195301-43A2-482E-8300-DC8536B6BCB5Q34691316-6A3CEA13-6FCC-40E0-A7F8-57C55C50F213Q34886447-2F195892-E86B-4302-B58F-87E3CE84E048Q35007043-7BE73B74-FAF9-41E8-8025-FAF6BA7DCB5EQ35385581-DE7AFFD3-6ACE-448D-B623-518C1681F650Q35778880-E14E936E-E7BE-428C-B88D-9AC660CDF06AQ35973691-06052AE1-4E5D-4613-98C5-587DE09B4F4AQ38458923-21142C66-9CFE-4E5A-8978-6F298DE192E6Q40151409-AD7CC115-C1CF-4D3D-8527-620E6E8AD439Q42722754-E34184DE-77A3-4C99-9266-44E1F4081A4CQ44440640-89CCAE02-417F-46D4-A478-ECD40F0E47D5Q46103032-A3CE488C-80AD-46E3-80B8-08970E1F989CQ46264155-C01D825D-467B-4504-B9A9-EA549D99ED54Q56781962-FD84F02F-8835-4E25-935C-7BCB4C728CF3
P2860
Uptake of HIV screening in genitourinary medicine after change to "opt-out" consent.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Uptake of HIV screening in genitourinary medicine after change to "opt-out" consent.
@ast
Uptake of HIV screening in genitourinary medicine after change to "opt-out" consent.
@en
type
label
Uptake of HIV screening in genitourinary medicine after change to "opt-out" consent.
@ast
Uptake of HIV screening in genitourinary medicine after change to "opt-out" consent.
@en
prefLabel
Uptake of HIV screening in genitourinary medicine after change to "opt-out" consent.
@ast
Uptake of HIV screening in genitourinary medicine after change to "opt-out" consent.
@en
P2093
P1433
P1476
Uptake of HIV screening in genitourinary medicine after change to "opt-out" consent.
@en
P2093
Belinda Stanley
Jane Fraser
P2860
P356
10.1136/BMJ.326.7400.1174
P407
P577
2003-05-01T00:00:00Z